Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Donald Kirkpatrick, PhD
CHIEF TECHNOLOGY OFFICER, INTERLINE THERAPEUTICS
Oncology Drug Discovery: Novel Approaches To Drug Discovery
Sahil Kirpekar, MD
CHIEF BUSINESS OFFICER, ATAI LIFE SCIENCES
A New Framework for Applying AI to Mental Health Drug Development
Tasuku Kitada
CO-FOUNDER, PRESIDENT, AND HEAD OF R&D, STRAND THERAPEUTICS
The Evolving Landscape of Immunotherapy in Solid Cancers
Placeholder Photo
Semra Kitchen, PhD
DIRECTOR, BUSINESS DEVELOPMENT - SEARCH AND EVALUATION, GSK
GSK
London, United Kingdom
Roger Kitterman, MBA
CO-FOUNDER AND MANAGING PARTNER, MASS GENERAL BRIGHAM VENTURES
Why Health Systems Are Funding the Commercialization of New Therapies: A New Player in Biotech Investing
Boston, Massachusetts, United States
Isaac Klein, MD, PhD
CHIEF SCIENTIFIC OFFICER, DEWPOINT THERAPEUTICS
Scientific Revolutions: New Therapies Meet New Biology
Matthias Kleinz, PhD,DVM
EVP, TRANSLATIONAL SCIENCES, UPMC ENTERPRISES
Why Health Systems Are Funding the Commercialization of New Therapies: A New Player in Biotech Investing
Pittsburgh, Pennsylvania, United States
Jackie Kline
VICE PRESIDENT, GLOBAL REGULATORY AFFAIRS, ONCOLOGY, AMGEN
Dose Optimization in Oncology: How Do We Tackle the Tricky Topic of Combinations?
Placeholder Photo
Eric Kmiec
CEO, CORRIXR THERAPEUTICS
CorriXR Therapeutics
Placeholder Photo
Jeremy Knox
HEAD OF POLICY, INFECTIOUS DISEASE, WELLCOME TRUST
Vaccine Manufacturing in Africa: Challenges and Opportunities